These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 26689442)

  • 1. New Clinical Strain of Neisseria gonorrhoeae with Decreased Susceptibility to Ceftriaxone, Japan.
    Deguchi T; Yasuda M; Hatazaki K; Kameyama K; Horie K; Kato T; Mizutani K; Seike K; Tsuchiya T; Yokoi S; Nakano M; Yoh M
    Emerg Infect Dis; 2016 Jan; 22(1):142-4. PubMed ID: 26689442
    [No Abstract]   [Full Text] [Related]  

  • 2. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.
    Wind CM; Schim van der Loeff MF; van Dam AP; de Vries HJ; van der Helm JJ
    Euro Surveill; 2017 Jan; 22(1):. PubMed ID: 28079519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility profile of
    Affolabi D; Goma E; Sogbo F; Ahotin G; Orekan J; Massou F; Behanzin L; Guédou F; Alary M
    Sex Transm Infect; 2018 Feb; 94(1):20. PubMed ID: 29021407
    [No Abstract]   [Full Text] [Related]  

  • 4. Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae.
    Matsumoto T
    Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S35-9. PubMed ID: 18164598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan.
    Ohnishi M; Saika T; Hoshina S; Iwasaku K; Nakayama S; Watanabe H; Kitawaki J
    Emerg Infect Dis; 2011 Jan; 17(1):148-9. PubMed ID: 21192886
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
    Morita-Ishihara T; Unemo M; Furubayashi K; Kawahata T; Shimuta K; Nakayama S; Ohnishi M
    J Antimicrob Chemother; 2014 Aug; 69(8):2086-90. PubMed ID: 24777907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug-resistant
    Terkelsen D; Tolstrup J; Johnsen CH; Lund O; Larsen HK; Worning P; Unemo M; Westh H
    Euro Surveill; 2017 Oct; 22(42):. PubMed ID: 29067905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017.
    Lefebvre B; Martin I; Demczuk W; Deshaies L; Michaud S; Labbé AC; Beaudoin MC; Longtin J
    Emerg Infect Dis; 2018 Feb; 24(2):381-3. PubMed ID: 29131780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rising trend of antimicrobial resistance among Neisseria gonorrhoeae isolates and the emergence of N. gonorrhoeae isolate with decreased susceptibility to ceftriaxone.
    Bharara T; Bhalla P; Rawat D; Garg VK; Sardana K; Chakravarti A
    Indian J Med Microbiol; 2015; 33(1):39-42. PubMed ID: 25560000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection.
    Bissessor M; Whiley DM; Fairley CK; Bradshaw CS; Lee DM; Snow AS; Lahra MM; Hocking JS; Chen MY
    Clin Infect Dis; 2015 Feb; 60(4):557-63. PubMed ID: 25371490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug-resistant
    Poncin T; Fouere S; Braille A; Camelena F; Agsous M; Bebear C; Kumanski S; Lot F; Mercier-Delarue S; Ngangro NN; Salmona M; Schnepf N; Timsit J; Unemo M; Bercot B
    Euro Surveill; 2018 May; 23(21):. PubMed ID: 29845928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
    Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
    Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain FC428, China.
    Chen SC; Han Y; Yuan LF; Zhu XY; Yin YP
    Emerg Infect Dis; 2019 Jul; 25(7):1427-1429. PubMed ID: 30900979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neisseria gonorrhoeae infections].
    Furuya R; Tanaka M
    Nihon Rinsho; 2009 Jan; 67(1):129-35. PubMed ID: 19177762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence and antibiotics susceptibility pattern of Neisseria gonorrhoeae in patients attending OPD clinics at St. Mary's Hospital Lacor Uganda.
    Amito Florence P; Otim F; Okongo F; Ogwang M; Greco D
    J Prev Med Hyg; 2012 Dec; 53(4):186-9. PubMed ID: 23469585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of a Rapid Genotypic Assay to Promote Targeted Ciprofloxacin Therapy of Neisseria gonorrhoeae in a Large Health System.
    Allan-Blitz LT; Humphries RM; Hemarajata P; Bhatti A; Pandori MW; Siedner MJ; Klausner JD
    Clin Infect Dis; 2017 May; 64(9):1268-1270. PubMed ID: 28034887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance patterns in
    Nacht C; Agingu W; Otieno F; Odhiambo F; Mehta SD
    Int J STD AIDS; 2020 Jan; 31(1):46-52. PubMed ID: 31870236
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011.
    Unemo M; Golparian D; Potočnik M; Jeverica S
    Euro Surveill; 2012 Jun; 17(25):. PubMed ID: 22748003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Australian Gonococcal Surveillance Programme, 1 April to 30 June 2015.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2015 Dec; 39(4):E628-30. PubMed ID: 26779739
    [No Abstract]   [Full Text] [Related]  

  • 20. Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014.
    Golparian D; Ohlsson A; Janson H; Lidbrink P; Richtner T; Ekelund O; Fredlund H; Unemo M
    Euro Surveill; 2014 Jul; 19(30):. PubMed ID: 25108533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.